Search

Author/Creator Beydoun, Said

11. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study. Issue 5 (May 2023)

Authors:
Bril, Vera; Drużdż, Artur; Grosskreutz, Julian; Habib, Ali A; Mantegazza, Renato; Sacconi, Sabrina; Utsugisawa, Kimiaki; Vissing, John; Vu, Tuan; Boehnlein, Marion; Bozorg, Ali; Gayfieva, Maryam; Greve, Bernhard; Woltering, Franz; Kaminski, Henry J; Genge, Angela; Massie, Rami; Berube, Maxime; Br...
Journal:
Lancet neurology
Issue:
Volume 22:Issue 5(2023)
Page Start:
383
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study. Issue 5 (May 2023)

Authors:
Howard, James F; Bresch, Saskia; Genge, Angela; Hewamadduma, Channa; Hinton, John; Hussain, Yessar; Juntas-Morales, Raul; Kaminski, Henry J; Maniaol, Angelina; Mantegazza, Renato; Masuda, Masayuki; Sivakumar, Kumaraswamy; Śmiłowski, Marek; Utsugisawa, Kimiaki; Vu, Tuan; Weiss, Michael D; Zajda, M...
Journal:
Lancet neurology
Issue:
Volume 22:Issue 5(2023)
Page Start:
395
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial. Issue 7 (July 2021)

Authors:
Howard, James F; Bril, Vera; Vu, Tuan; Karam, Chafic; Peric, Stojan; Margania, Temur; Murai, Hiroyuki; Bilinska, Malgorzata; Shakarishvili, Roman; Smilowski, Marek; Guglietta, Antonio; Ulrichts, Peter; Vangeneugden, Tony; Utsugisawa, Kimiaki; Verschuuren, Jan; Mantegazza, Renato; De Bleecker, Jan...
Journal:
Lancet neurology
Issue:
Volume 20:Issue 7(2021)
Page Start:
526
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗